199
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and characterization of new bis(fluoroalkyl) phosphoramidates bearing sulfoximine groups

, , &
Pages 547-559 | Received 17 Mar 2021, Accepted 11 May 2021, Published online: 25 May 2021
 

Abstract

A series of new sulfoximine derived bis(fluoroalkyl)phosphoramidates of the type MeRS(O)NP(O)(ORF)2 (R = Me or Ph; RF = CH2CF3, CH2C2F5, CH(CF3)2, CH2CH2C6F13 or CH2CH2C8F17) have been synthesized from phosphoramidation reaction of sulfoximine with bis(polyfluoroalkyl)phosphites as phosphorylating agents. These fluoroalkyl phosphoramidates were characterized by multinuclear (1H, 13C, 19F and 31P) NMR, IR and elemental analyses. Different literature methods were examined; results showed that whilst the presence of fluoroalkoxy groups gave better reactivity than non fluorinated analogs in such reactions, the choice of the method for phosphoramidate formation depended upon the nature of both sulfoximine and fluoroalkoxy groups.

GRAPHICAL ABSTRACT

Acknowledgements

We are grateful to the Tunisian Ministry of High Education and Scientific Research for financial support (LR99ES14) of this research.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by Tunisian Ministry of High Education and Scientific Research [grant number (LR99ES14)].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.